The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe. UVA Health scientists are calling for clinical trials testing the ...

As researchers make progress in understanding how Alzheimer's disease develops, there are growing opportunities for healthy research participants to learn their risk of developing Alzheimer's ...

The researchers, led by UVA's Jayakrishna Ambati, MD, previously identified a possible mechanism by which the drugs could prevent Alzheimer's. That promising finding prompted them to analyze two ...

CLEVELAND, Ohio -- For the first time, the number of Americans living with Alzheimer’s disease is more than 7 million, and deaths due to the illness are increasing, according to a new report.

UVA Health researchers say drugs used to treat HIV could help prevent a million new cases of Alzheimer’s each year – and they want clinical trials to find out. UVA’s Dr. Jayakrishna Ambati and his ...

Dr. Charles DeCarli, co-director of the UC Davis Alzheimer’s Research Center, got the news in a call from a colleague on March 24. “Your study was terminated.” DeCarli had been conducting a ...

For decades, Alzheimer’s disease has been seen as a one-way road, a slow but inevitable decline in memory and thinking. But new research out of Harvard is beginning to challenge that assumption.

Positron Emission Tomography (PET) scans today can be used to determine your risk of Alzheimer's via the detection of amyloid beta plaques. © Utthapon wiratepsupon ...

May is the month where the spotlight shines on women’s health. Did you know nearly two-thirds of Americans with Alzheimer’s disease are women? According to the Alzheimer’s Association ...

While Alzheimer’s disease is mostly considered a disorder of the brain, emerging evidence suggests that the condition also affects other organs of the body. Working with the laboratory fruit fly, ...

Four South Florida clinics are enrolling patients in a nationwide trial for a vitamin that may offer a solution for slowing memory loss and halting the progression of Alzheimer’s disease.

To the editor: I really appreciate that Steve Lopez wrote a powerful column calling attention to the insanity of cutting off the funding for an ambitious study of Alzheimer’s (“7 million ...